Invention Grant
- Patent Title: Human lymphocyte vaccine adjuvant
- Patent Title (中): 人淋巴细胞疫苗佐剂
-
Application No.: US12824577Application Date: 2010-06-28
-
Publication No.: US08088397B2Publication Date: 2012-01-03
- Inventor: Kenichiro Hasumi , Dean LeMar Mann , Kim Graulich Hankey , Kristina Michelle Holt
- Applicant: Kenichiro Hasumi , Dean LeMar Mann , Kim Graulich Hankey , Kristina Michelle Holt
- Applicant Address: US NY New York US MD Baltimore
- Assignee: Hasumi, LLC,University of Maryland, Baltimore
- Current Assignee: Hasumi, LLC,University of Maryland, Baltimore
- Current Assignee Address: US NY New York US MD Baltimore
- Agency: Acker Wood IP Law, LLC
- Agent Gwen R. Acker Wood
- Main IPC: A61K45/00
- IPC: A61K45/00 ; G01N33/00
Abstract:
The present invention relates to an adjuvant derived from human lymphocytes. The adjuvant can be used in combination with traditional vaccines or cancer immunotherapy, to enhance the response of the patient's immune system to the vaccine or other immunotherapeutic agent. The adjuvant is derived from the supernatant collected from cultured activated lymphocytes.
Public/Granted literature
- US20100266534A1 Human Lymphocyte Vaccine Adjuvant Public/Granted day:2010-10-21
Information query
